XRCC3 is a promising target to improve the radiotherapy effect of esophageal squamous cell carcinoma.
about
Derlin-1 is a target to improve radiotherapy effect of esophageal squamous cell carcinoma.Characterization of titanium dioxide nanoparticles modified with polyacrylic acid and H2O2 for use as a novel radiosensitizer.High expression of Rad51c predicts poor prognostic outcome and induces cell resistance to cisplatin and radiation in non-small cell lung cancer.
P2860
XRCC3 is a promising target to improve the radiotherapy effect of esophageal squamous cell carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
XRCC3 is a promising target to ...... ageal squamous cell carcinoma.
@ast
XRCC3 is a promising target to ...... ageal squamous cell carcinoma.
@en
type
label
XRCC3 is a promising target to ...... ageal squamous cell carcinoma.
@ast
XRCC3 is a promising target to ...... ageal squamous cell carcinoma.
@en
prefLabel
XRCC3 is a promising target to ...... ageal squamous cell carcinoma.
@ast
XRCC3 is a promising target to ...... ageal squamous cell carcinoma.
@en
P2093
P2860
P356
P1433
P1476
XRCC3 is a promising target to ...... ageal squamous cell carcinoma.
@en
P2093
Chao Jiang
Hongqing Zhuang
Huanhuan Wang
Jingjing Cheng
Lujun Zhao
Maobin Meng
P2860
P304
P356
10.1111/CAS.12820
P577
2015-09-18T00:00:00Z